相关实验视频
Updated: Jul 19, 2025

07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
29.9K
内皮细胞中的Caveolin-1:一种潜在的动脉样硬化治疗点
1Department of Endocrinology, Institute of Geriatric Medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, 39 Lake Road, East Lake Ecological Scenic, Wuhan, 430077, China.
Heliyon
|August 9, 2023
概括
卡维奥林-1 (Cav1) 通过影响内皮细胞反应,在动脉样硬化 (AS) 的发展中发挥关键作用. 准Cav1为预防AS和开发早期治疗干预提供了一个新的策略.
科学领域:
- 心血管生物学 心血管生物学
- 细胞和分子医学 细胞和分子医学
- 生物化学 生物化学
背景情况:
- 动脉样硬化 (AS) 是主要的死亡原因,由内皮细胞激活和功能障碍驱动.
- 内皮细胞是AS压力因素的第一个响应者,如氧化脂蛋白和炎症.
- 卡维奥林-1 (Cav1) 在内皮细胞中高度表达,并与AS病原发生有关.
研究的目的:
- 审查AS发展中的Cav1的结构,功能和机制.
- 探索Cav1在内皮细胞自,剪切应激反应和炎症信号传递中的作用.
- 确定Cav1作为早期AS预防的潜在治疗点.
主要方法:
- 关于Cav1和AS的最近研究的文献综述.
- 对Cav1参与内皮细胞信号通路的分析.
- 检查Cav1在脂质运输和炎症中的作用.
主要成果:
- Cav1调节内皮细胞自和对剪切压力的反应.
- 卡维1调节eNOS/NO轴,影响血管功能.
- 在Cav1中介的炎症信号通路有助于AS.
结论:
- 在动脉样硬化的发展中,Cav1是关键的调解者.
- 向Cav1为AS早期干预提供了一个新的治疗策略.
- 对Cav1机制的进一步研究可以导致创新的AS预防方法.
相关概念视频
Atherosclerosis I: Introduction
10
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Cholesterol: Significance and Regulation
584
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
584
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
201
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
201

